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Ovarian endometriosis is a recognized risk for infertility and epithelial ovarian cancer, presumably due to
iron overload resulting from repeated hemorrhage. To ﬁnd a clue for early detection and prevention of
ovarian endometriosis-associated cancer, it is mandatory to evaluate catalytic (labile) ferrous iron (cat-
alytic Fe(II)) and to study iron manipulation in ovarian endometriotic lesions. By the use of tissues from
women of ovarian endometriosis as well as endometrial tissue from women with and without en-
dometriosis, we for the ﬁrst time performed histological analysis and cellular detection of catalytic Fe(II)
with a speciﬁc ﬂuorescent probe (HMRhoNox-M), and further evaluated iron transport proteins in the
human specimens and in co-culture experiments using immortalized human eutopic/ectopic en-
dometrial stromal cells (ESCs) in the presence or absence of epithelial cells (EpCs). The amounts of
catalytic Fe(II) were higher in ectopic endometrial stromal cells (ecESCs) than in normal eutopic en-
dometrial stromal cells (n-euESCs) both in the tissues and in the corresponding immortalized ESCs.
ecESCs exhibited higher transferrin receptor 1 expression both in vivo and in vitro and lower ferroportin
expression in vivo than n-euESCs, leading to sustained iron uptake. In co-culture experiments of ESCs
with iron-loaded EpCs, ecESCs received catalytic ferrous iron from EpCs, but n-euESCs did not. These data
suggest that ecESC play a protective role for cancer-target epithelial cells by collecting excess iron, and
that these characteristics are retained in the immortalized ecESCs.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Endometriosis is an estrogen-dependent chronic inﬂammatory
disease in which epithelial and stromal cells similar to the normal
endometrial structure exist outside the uterine cavity [1–3]. The
morbidity of endometriosis reaches 6–10% in women of re-
productive age, and the patients suffer from dysmenorrhea, dys-
pareunia, chronic pelvic pain and infertility [1–3]. Furthermore, it
is recognized that ovarian endometriosis is a risk factor for ovarianB.V. This is an open access article u
ls; ecESCs, ectopic ESCs (im-
sis (immortalized); n-euESCs,
ortalized); EpCs, epithelial
ry protein or iron-responsive
Toyokuni).cancer such as clear cell adenocarcinoma and endometrioid ade-
nocarcinoma [4,5].
Ovarian endometriosis causes local iron deposition due to re-
peated monthly hemorrhage [6,7]. Iron is the most abundant heavy
metal in the human body and is essential as an oxygen transporter
and a cofactor for various enzymes [8]. However, iron excess in-
creases catalytic iron and leads to different classes of diseases,
including diabetes mellitus [9], liver cirrhosis [10] and cancer [6].
Catalytic ferrous iron (catalytic Fe(II)) reacts with hydrogen per-
oxide to produce the hydroxyl radical in a Fenton reaction [11,12].
Hydroxyl radicals not only react with lipids and proteins but also
causes oxidative damage to DNA, resulting in base modiﬁcations
and strand breaks [13–16]. Endometriotic cysts present extremely
high concentrations of catalytic iron compared with normal serum
and the contents of other ovarian tumors. Indeed, the epithelia
covering endometriotic cysts contain a high level of oxidative DNA
damage compared with other ovarian tumors [17,18], which may
be a major pathology for carcinogenesis [19,20].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fe(II), named RhoNox-1, was developed [21]. Recently, we re-
ported on an increase in catalytic Fe(II) in the target cells of a rat
model of iron-induced renal cancer [22] and in amniotic ﬂuid of
human maternal-fetal disorders [23], using RhoNox-1. Further-
more, a new class of high-contrast ﬂuorescent probes for catalytic
Fe(II), called HMRhoNox-M, in which the turn-on contrasts were
signiﬁcantly improved compared with those of RhoNox-1, was
described [24].
Mesenchymal tissue, represented by bone, cartilage, muscle
and adipose tissue, not only connects and supports organs but also
forms scaffolds for epithelial cells, thus playing a role in physio-
logical functions. The Müllerian duct is a mesodermal precursor of
the female genital tract, from which the uterus originates. The
Müllerian duct comprises mesoepithelia and the mesenchyme
surrounding them. Thus, endometrial epithelia originate from
mesoepithelia, whereas endometrial stroma originate from the
surrounding mesenchyme [25,26]. Of note, erythrocytes and ske-
letal muscle, derived from mesoderm and mesenchyme, use a
large amount of iron for oxygen transport and storage. Liver, de-
rived from endoderm, is the largest iron storage organ. However,
mesenchymal stem cells can reportedly differentiate into hepato-
cytes [27], thus indicating a link between mesoderm and iron
storage.
The relationship between endometriosis and catalytic Fe(II) are
presently unknown. Here, for the ﬁrst time, we studied the loca-
lization of catalytic Fe(II) in endometriotic lesions and the asso-
ciated endometrial(-otic) stromal cells with a selective turn-on
ﬂuorescent probe for catalytic Fe(II) to consider a possible role of
ectopic endometrial stromal cells as a storage site for excess iron.2. Materials and methods
2.1. Materials
HMRhoNox-M was prepared according to the reported proce-
dure [24]. We purchased iron (III) chloride hexahydrate (Wako,
Osaka, Japan), LysoTracker (Molecular Probes, Eugene, OR), Mito-
Tracker (Molecular Probes), CellTracker Green CMFDA (Molecular
Probes), Hoechst 33342 (Molecular Probes), Cellmatrix Type I-P
collagen (Nitta Gelatin, Inc., Osaka, Japan), anti-human transferrin
receptor antibody (Zymed, 13-6800; San Francisco, CA), anti-fer-
roportin 1 antibody (Novus Biologicals, NBP1-21502; Littleton, CO),
anti-CD10 monoclonal antibody (Novocastra, NCL-L-CD10-270;
Newcastle, UK), anti β-actin monoclonal antibody (Wako, 011-
24554; Tokyo, Japan), Stealth siRNAs for human transferrin re-
ceptor 1 (TfR1) (HSS110674, HSS110676 and HSS186305) and a
non-targeting siRNA (HSS12935-112) as a negative control (In-
vitrogen, Carlsbad, CA). We prepared ferric nitrilotriacetate (Fe
(III)-NTA) solution by mixing 300 mM ferric nitrate and 600 mM
nitrilotriacetate, followed by pH adjustment to 7.4 with sodium
hydrogen bicarbonate as described [28]. The other chemicals were
of analytical grade.
2.2. Prussian blue staining
Prussian blue staining to detect insoluble iron was performed
with freshly prepared 2% potassium ferrocyanide and 2% hydro-
chloric acid. Following a 30 min incubation, the sections were
rinsed in water and counterstained with nuclear fast red, dehy-
drated, and covered. The slide images were captured with a BZ-
9000 microscope (Keyence, Osaka, Japan).2.3. Histological analysis of catalytic ferrous iron
HMRhoNox-M was stored at 80 °C and dissolved in di-
methylsulfoxide to produce a 10 mM solution, which was further
diluted (1:1000) with 10 mM phosphate-buffered saline (pH 7.2)
(PBS) before use to a ﬁnal concentration of 10 μM. Frozen sections
were cut at a thickness of 8 μm with a cryostat onto MAS-GP type
A grass slides (Matsunami, Osaka, Japan), air dried for 5 min, ﬁxed
for 3 min in 10 mM PBS-buffered 20% formalin in methanol, and
washed for 5 min in PBS. Thereafter, an ample amount of 10 mM
HMRhoNox-M was applied on these specimens, followed by in-
cubation for 30 min at 37 °C in a dark box and rinse in PBS. Then,
the specimens were counterstained with Hoechst 33342 and
captured with a BZ-9000 microscope.
2.4. Cell culture experiments
Endometrial(-otic) stromal cells were established using E6, E7
and hTERT (lentiviruses and retroviruses) as previously described
[29–31]. Immortalized endometrial stromal cells were maintained
in phenol red Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Sig-
ma, St. Louis, MO) containing 10% fetal bovine serum (Biological
Industries, Beit Haemek, Israel), 100 IU/mL of penicillin, 100 mg/L
of streptomycin and 25 mg/L of amphotericin B. A well-differ-
entiated human endometrioid adenocarcinoma cell line named
“Ishikawa” was a generous gift from Dr. Masato Nishida (Kasu-
migaura Hospital, Ibaraki, Japan) [32]. Ishikawa cells, as a model of
endometrial epithelial cells (EpCs), were maintained in RPMI 1640
(Sigma) containing 10% fetal bovine serum, 100 IU/mL of penicillin
and 100 mg/L of streptomycin. These cells were incubated at 37 °C
in a humidiﬁed atmosphere of 5% CO2, as previously described
[31]. In the present study, immortalized normal eutopic en-
dometrial stromal cells, immortalized eutopic endometrial stromal
cells of endometriosis and immortalized ectopic endometrial
stromal cells were abbreviated as n-euESCs, e-euESCs and ecESCs,
respectively. Three cell lines from different patients, respectively,
were established, and data were collected at least in triplicate.
2.5. Patients and human samples
The ethics committee (internal review board) of the Nagoya
University Graduate School of Medicine approved the experiments
(no. 4884). Written informed consent was obtained from each
patient before sampling. Parafﬁn-embedded tissues of ovarian
endometriosis from three patients, endometrium from three pa-
tients with endometriosis and endometrium from three patients
without endometriosis who had been resected for therapeutic
purposes at Nagoya University Hospital were used for im-
munohistochemical analyses. Tissues of ovarian endometriosis for
frozen section were obtained from three patients with en-
dometriosis. Tissues of adenomyosis for frozen section were ob-
tained from one patient. Normal endometrial tissues for frozen
section were obtained from three patients with Stage IA1 or IB1
cervical adenocarcinoma without endometriosis.
2.6. Immunohistochemistry
All samples were ﬁxed in 10 mM PBS-buffered 10% formalin
and embedded in parafﬁn, and sections were cut at a thickness of
4 mm. For antigen retrieval, the sections, following deparafﬁniza-
tion, were heated at 95 °C in Tris-EDTA buffer (10 mM Tris base,
1 mM EDTA solution, pH 9.0) with a microwave oven for 20 min.
Immunohistochemical staining was performed by employing the
avidin-biotin immunoperoxidase technique using the Histoﬁne
SAB-PO kit (Nichirei, Tokyo, Japan) according to the manufacturer's
protocol. Endogenous peroxidase activity was blocked by
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immunoglobulin binding was blocked by incubation for 10 min in
10% normal serum in PBS with the corresponding species of the
secondary antibody. The sections were incubated at 4 °C overnight
with anti-human transferrin receptor antibody (1:500), anti-fer-
roportin 1 antibody (1:1000) and anti-CD10 (1:50). The sections
were then rinsed and incubated with biotinylated secondary
antibody for 10 min. After washing with PBS, the sections were
incubated with horseradish peroxidase-conjugated streptavidin
for 5 min and ﬁnally treated with diaminobenzidine in 0.01% H2O2
for 5 min. The slides were counterstained with Meyer’s hema-
toxylin. Whole slide images were captured with a BZ-9000
microscope.
2.7. Morphological analyses with LysoTracker/MitoTracker and
HMRhoNox-M
n-euESCs, e-euESCs and ecESCs (ESCs) were incubated for
30 min at 37 °C with 250 nM LysoTracker or 50 nM MitoTracker in
Hank’s balanced salt solution (HBSS) (GIBCO, Carlsbad, CA), rinsed
in HBSS and incubated for 30 min at 37 °C with 10 mM of
HMRhoNox-M with HBSS, followed by rinse in HBSS and ob-
servation with a confocal laser microscope, TiEA1R (Nikon Instech
Co., Tokyo, Japan). The ﬂuorescence intensity of HMRhoNox-M and
LysoTracker/MitoTracker in the cytoplasm was quantiﬁed with
NIS-Elements imaging software (Nikon Instech Co.).
2.8. Protein extraction techniques and western blot analysis
Protein extraction techniques and western blot analysis were
performed as described [33]. Brieﬂy, ESCs were washed with PBS,
lysed in RIPA buffer [10 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1%
Nonidet P-40, 5 mM EDTA, 1% sodium deoxycholate, 0.1% sodium
dodecyl sulfate (SDS), 1.2% aprotinin, 5 mM leupeptin, 4 mM anti-
pain, 1 mM phenylmethyl sulfonyl ﬂuoride, and 0.1 mM Na3VO4],
homogenized on ice, centrifuged at 20,630g at 4 °C for 20 min, and
diluted in 2x sample buffer [125 mM Tris–HCl (pH 6.8), 4% SDS,
10% glycerol, 0.2% bromophenol blue and 4% 2-mercaptoethanol].
After boiling at 95 °C for 5 min, the samples were analyzed with
10% SDS-polyacrylamide gel electrophoresis (PAGE). The proteins
separated by SDS-PAGE were transferred to polyvinylidene di-
ﬂuoride (PVDF) membrane, followed by incubation for 1 h with 5%
skim milk in Tris-buffered saline containing 0.05% Tween 20. The
membrane was then incubated overnight at 4 °C with primary
antibody; anti-transferrin receptor antibody (1:2000) or anti-β-
actin antibody (1:3000). The membrane was washed three times
with Tween-PBS for 10 min, followed by incubation with anti-
mouse IgG HRP-linked antibody (#7076 S, 1:2000; Cell Signaling
Technology, Danvers, MA) as a secondary antibody for 1 h. After
washing with Tween-PBS, the membrane was reacted with
Amersham ECL Western blot detecting reagent (GE Healthcare,
Buckinghamshire, UK) and the chemiluminescence was detected.
β-actin was used as an internal control.
2.9. Iron loading and transfer experiment under co-culture of ESCs
and epithelial cells
Either epithelial cells (EpCs; Ishikawa cells) or ESCs were in-
cubated in the corresponding medium with 50 mM FeCl3 or Fe(III)-
NTA for 12 h, while the cells that were not exposed to iron were
incubated in serum-free medium for 12 h. ESCs were labeled with
2 mM CellTracker Green CMFDA for the ﬁnal 1 h according to the
manufacturer’s protocol. EpCs and ESCs were mixed and seeded at
3.5105 cells, each, per 35 mm glass-base dish (IWAKI, Tokyo,
Japan) coated with collagen (Cellmatrix Type I–P), according to themanufacture’s protocol. After 6 h, the mixed cells were incubated
with 10 mM of HMRhoNox-M in HBSS for 1 h and counterstained
with Hoechst 33342 for 30 min. Then, the images were captured
with a BZ-9000 microscope.
2.10. RNA interference
TfR1 expression was silenced with three siRNA preparations.
Three siRNAs targeting human TfR1 sequences and a non-targeting
siRNA, as a negative control per the manufacturer's re-
commendation, were purchased as described. ecESCs were seeded
at 2.5106 cells per 60 mm collagen-coated dish, incubated in
DMEM with 10% FBS for 12 h, and then incubated in DMEM
without serum for 24 h. This was followed by transfection with
each siRNA (30 nM) with Lipofectamine RNAiMAX according to
the manufacturer’s protocol. The media was changed to DMEM
with 10% FBS after 24 h. Silencing of TfR1 expression was con-
ﬁrmed at 48 h with western blot analysis. Data were collected
using three different ecESCs.
2.11. Statistical analysis
Date is shown as the mean7SEM. A one-way ANOVA test
followed by a Tukey HSD test or an unpaired Student's t-test was
applied using SPSS version 22.0 (SPSS Inc., Chicago, IL). Po0.05
was considered statistically signiﬁcant.3. Results
3.1. Distribution of catalytic Fe(II) in human specimens
ecESCs of endometriotic cysts revealed the strongest HMRho-
Nox-M ﬂuorescence, indicating an abundance of catalytic Fe(II)
(Fig. 1a–h). The localization of hemosiderin was independent of
that of catalytic Fe(II) iron (Fig. 1g–j). Normal endometrium
showed a small amount of catalytic Fe(II) (Fig. 1k–n). ecESCs of
adenomyosis within the uterine muscle layer showed a larger
amount of catalytic Fe(II) compared with the euESCs (Fig. 1o–r).
3.2. Intracellular localization of catalytic Fe(II) in ESCs
Catalytic Fe(II) in the immortalized ESCs as seen by HMRho-
Nox-M was mostly located in lysosomes, and partially in mi-
tochondria (Supplemental Fig. 1). There was no signiﬁcant differ-
ence in the distribution of lysosomes, mitochondria and the as-
sociated catalytic Fe(II) among different ESCs.
3.3. Effects of iron loading on catalytic Fe(II) in ESCs
We then evaluated the alteration of catalytic Fe(II) in n-euESCs,
e-euESCs and ecESCs after treatment with 0, 10, 25 and 50 mM
FeCl3 for 6 h (Fig. 2A). At any dose of FeCl3, ecESCs and e-euESCs
showed high catalytic Fe(II) compared with that of n-euESCs.
Catalytic Fe(II) of endometriosis-associated stromal cells (ecESCs
and e-euESCs) increased in a dose-dependent manner up to 50 μM
FeCl3. In contrast, catalytic Fe(II) of n-euESCs increased at 10 mM
FeCl3 but decreased at 25 and 50 mM FeCl3. Simultaneously we
performed a time-course study on catalytic Fe(II) in n-euESCs,
e-euESCs and ecESCs after treatment with 50 mM FeCl3 (Fig. 2B). At
any time after FeCl3 treatment, endometriosis-associated stromal
cells presented higher catalytic Fe(II) than that of n-euESCs. Cat-
alytic Fe(II) of ecESCs increased in a time-dependent manner.
However, catalytic Fe(II) of n-euESCs and e-euESCs increased with
Fig. 1. Abundant catalytic ferrous iron (catalytic Fe(II)) is detected in endometriotic tissue in the ovary and in adenomyosis lesions within the uterine muscle layer. We
performed histological detection for catalytic Fe(II) with HMRhoNox-M. The frozen sections of a–j, k–n and o–r are generated from endometriotic cysts, normal endometrium
and endometrium of adenomyosis, respectively. Hematoxylin and eosin staining of ectopic or eutopic endometrial epithelium and stroma (a, e, f, k, o). HMRhoNox-M
ﬂuorescent staining of catalytic Fe(II) (b, g, h, l, p, q, r). Hoechst 33342 nuclear staining (c, m). Merged with catalytic Fe(II) and nuclear staining (d, n). Prussian blue staining
shows hemosiderin (i, j). Scale bars¼100 mm.
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tained similar results with the use of Fe(III)-NTA instead of FeCl3.
3.4. Distinct responses of transferrin receptor 1 (TfR1) and ferro-
portin after iron loading in ESCs in vitro and in human specimens
After the treatment of ESCs with 0–100 mM Fe(III)-NTA for 6 h,
TfR1 protein increased in a dose-dependent manner in all the ESCs
(Fig. 3A). In a time-course study with 50 mM Fe(III)-NTA, TfR1
protein levels in n-euESCs and e-euESCs increased up to 12 h and
decreased at 24 h. In contrast, TfR1 protein in ecESCs continuously
increased up to 24 h (Fig. 3A). We obtained similar results with the
use of FeCl3 instead of Fe(III)-NTA.In human specimens, TfR1 protein levels in the stromal cells of
endometrium from ovarian endometriosis patients and en-
dometriotic cysts were higher than in the stromal cells of normal
endometrium (Fig. 3B). Ferroportin protein levels in the stromal
cells of normal endometrium and endometrium of ovarian en-
dometriosis were higher than in the stromal cells of endometriotic
cysts, which showed almost no ferroportin (Fig. 3B). Ectopic en-
dometrial stromal cells were conﬁrmed with CD10 (Fig. 3B).
3.5. Transfer of catalytic ferrous iron from EpCs to ESCs
We then evaluated which cells, EpCs or ESCs, have a higher af-
ﬁnity for catalytic Fe(II). Either EpCs or ESCs were preloaded with
Fig. 2. Distinct catalytic Fe(II) response in endometriosis-associated stromal cells. We performed the detection of catalytic Fe(II) in immortalized ESCs. (A) HMRhoNox-M
speciﬁc ﬂuorescence in n-euESC, e-euESCs and ecESCs after treatment of 0, 10, 25 and 50 mM FeCl3 for 6 h. We compared the ﬂuorescence intensity (mean7SEM) of each
ESCs with the same dose of FeCl3 and each dose in the same cell. Multiple comparisons with integrated ﬂuorescence intensity per cell were performed using the Tukey HSD
test to determine signiﬁcant differences between each pair of cells. The statistics of a one-way ANOVA test were calculated using SPSS version 22.0 (SPSS Inc., Chicago, IL).
Scale bars¼50 mm. n po0.05, nn po0.01 vs n-euESC; § po0.05, §§ po0.01, ‡ po0.01, ¶¶ po0.01 vs 0 μM. (B) HMRhoNox-M speciﬁc ﬂuorescence in n-euESCs, e-euESCs and
ecESCs after treatment with 50 mM FeCl3 for 0, 6, 12 and 24 h. We compared the ﬂuorescence intensity (mean7SEM) of each ESCs with the same FeCl3 treatment time and
each treatment time in the same cell. Statistical analyses and the symbols are the same as in (A) except § po0.05, §§ po0.01, ‡ po0.01, ¶¶ po0.01 vs 0 h.
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green ﬂuorescent cell tracker (CMFDA) and were co-cultured with
EpCs thereafter. After an incubation of 6 h, we evaluated catalytic Fe
(II) in EpCs and ESCs (Fig. 4A). Catalytic Fe(II) in ecESCs was sig-
niﬁcantly higher than that in EpCs, irrespective of iron loading
(Fig. 4B). Under the cell culture conditions that ecESCs were in-
cubated, where there was twice the number ecESCs as iron-loaded
EpCs, catalytic Fe(II) in ecESCs was still signiﬁcantly higher than in
EpCs. However, under the conditions where the ratio of iron-loaded
EpCs:ecESCs was 2:1, the amounts of catalytic Fe(II) in EpCs and
ecESCs were not signiﬁcantly different (Fig. 4C). Of note, in the co-
culture experiment where ecESCs were replaced by either n-euESCs
or e-euESCs, catalytic Fe(II) was retained in the EpCs or the amounts
were not signiﬁcantly different, respectively (Fig. 4D). Finally, we
conﬁrmed with siRNA experiments that the increased catalytic Fe
(II) in ecESCs co-cultured with EpCs was dependent on TfR1. Si-
lencing of TfR1 expression was conﬁrmed with western blot ana-
lysis. After the knockdown of TfR1, the amounts of catalytic Fe(II) in
EpCs and ecESCs were not signiﬁcantly different (Fig. 4E).4. Discussion
Although catalytic ferrous iron is important as an initiator of
the Fenton reaction and has been implicated in various human
pathologic conditions [34], methods to localize it were not avail-
able until recently [21,22]. Here, for the ﬁrst time, we applied this
method to human ovarian endometriosis, with special reference to
the associated stromal cells [29]. For this method, frozen sections
were required, based on our preliminary experiments.
Iron overload in ovarian endometriosis is thought to be a major
pathogenic factor for carcinogenesis [4,6,35]. Thus, it is important
to evaluate the presence of catalytic Fe(II) in these lesions. We
observed abundant catalytic Fe(II), especially in the surrounding
stromal cells facing endometriotic lumina (Fig. 1) where its
amount was much higher than in the ESCs of control patients and
the highest among the human specimens in the present study.
Stromal cells in adenomyosis also showed higher catalytic Fe(II).
Importantly, the distribution of catalytic Fe(II) was distinct from
that of hemosiderin, which was generally present in macrophages
Fig. 3. Distinct responses of transferrin receptor 1 (TfR1) and ferroportin after iron loading in ESCs in vitro and in human specimens. (A) Protein levels of TfR1 in n-euESC,
e-euESCs and ecESCs treated with 0, 50, 100 mM Fe(III)-NTA for 6 h were analyzed with western blot (left panels). Protein levels of TfR1 in n-euESCs, e-euESCs and ecESCs
treated with 50 mM Fe(III)-NTA for 0, 6, 12, and 24 h were analyzed with western blot (right panels). Refer to the text for details. (B) Immunohistochemical analysis of TfR1
and ferroportin in normal endometrium, endometrium of endometriosis and endometriotic cysts. Refer to the text for details; scale bars¼100 mm.
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We observed that catalytic Fe(II) of ESCs as seen by HMRho-
Nox-M was located primarily in lysosomes and partially in mi-
tochondria (Supplemental Fig. 1). In mammalian cells, serum
transferrin that is ﬁlled with two Fe(III) atoms (holo-transferrin)
binds to TfR1 on the plasma membrane and this complex is en-
docytosed and fuses with lysosomes [36]. Fe(III) that is in-
corporated as a transferrin/TfR1 complex is released and is im-
mediately reduced to Fe(II) by STEAP3, followed by transport to
the cytosol through DMT1, then to its ﬁnal destination. The pre-
sence of Fe(II) is necessary for energy generation, heme synthesis
in the mitochondria, DNA synthesis/repair and iron storage within
the ferritin core [37–39]. Our data suggest that catalytic Fe(II) in
ESCs is under physiological control but that lysosomal and mi-
tochondrial iron pools would be larger during iron overload.
The present results using three different types of immortalized
ESCs [29] showed intriguing results. Namely, ecESCs revealedsigniﬁcantly higher iron storing capacity as evidenced by higher
amounts of catalytic Fe(II), not only under dose-dependent condi-
tions but also time-dependent. e-euESCs showed some similarity to
ecESCs (Fig. 2), which may partly explain the increased infertility in
women of reproductive age with endometriosis. To explain this
difference, we evaluated protein levels of TfR1 and ferroportin, the
only iron exporter from cells. In ecESCs and e-euESCs, TfR1 levels
continued to be higher in a time-course study whereas low TfR1
level presumably via feedback mechanismwas evident for n-euESCs
(Fig. 3A). We obtained similar results in human specimens for TfR1,
where continued iron deposition is occurring via repeated monthly
hemorrhage. Further, there was almost no ferroportin protein in the
stromal cells surrounding endometriotic cysts, strengthening this
“catalytic Fe(II)-abundant” situation, which was not observed in
normal endometrium (Fig. 3B).
Oxidative stress via excess iron leads to genetic and epigenetic
changes, uncontrolled cell growth, and abnormal intracellular
Fig. 4. ecESCs, not n-euESCs/e-euESCs, can receive catalytic Fe(II) from endometrial epithelial cells (EpCs) through TfR1. (A) The schema for the current co-culture method of
EpCs and ESCs. (B) Co-culture of ecESCs preloaded with FeCl3 and EpCs that were not preloaded with FeCl3 (upper row, p¼0.029). Co-culture of EpCs preloaded with FeCl3
and ecESCs that were not preloaded with FeCl3 (bottom row, p¼0.012). Total seeded cell number was 7.0105 cells (3.5105 EpCs and 3.5105 ecESCs). Arrows, ecESCs;
arrowheads, EpCs. Fluorescence intensity of HMRhoNox-M in EpCs and ecESCs was expressed as the mean7SEM; scale bars¼50 mm. (C) Altering the ratio of EpCs and
ecESCs (left: 4.0105 EpCs and 8.0105 ecESCs, p¼0.003; right: 8.0105 EpCs and 4.0105 ecESCs, p¼0.065). Arrowheads, EpCs; scale bars¼50 mm; NS, not signiﬁcant.
(D) Co-culture of EpCs and n-euESCs (p ¼0.001), and EpCs and e-euESCs (p¼0.083). Total seeded cell number was 7.0105 cells (3.5105 EpCs and 3.5105 euESCs).
Arrowheads, EpCs; scale bars¼50 mm; NS, not signiﬁcant. (E) Co-culture of EpCs preloaded with FeCl3 and ecESCs, transfected with TfR1 siRNA but not preloaded with FeCl3
(p¼0.095). Western blotting analysis conﬁrms the knockdown of TfR1 in ecESCs. Arrows, ecESCs; arrowheads, EpCs; scale bars¼50 mm. (B-E) * po0.05, ** po0.01, NS, not
signiﬁcant; unpaired Student's t-test.
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M. Mori et al. / Redox Biology 6 (2015) 578–586 585signaling [7,16,40,41]. Therefore, endometriosis might be a dis-
order of TfR1 dysregulation through ron regulatory protein 1
(IRP1) or iron regulatory protein 2 (IRP2) in the cytosol. Surpris-
ingly, similar traits for iron manipulation are retained in the three
different types of immortalized ESCs. We believe that the regula-
tion of TfR1 message via the IRP1 or IRP2 in the case of iron excess
works appropriately in n-euESCs and e-euESCs. However, this does
not work in ecESCs. In a previous experiment, we reported over-
expression of IRP1/IRP2 and FBXL5 in ecESCs [31]. Abundant IRP1/
IRP2 appears to be associated with the signaling for “iron uptake.”
A more precise description of the mechanism requires further
experiments.
Finally, we performed a study to determine which cell, EpCs or
ESCs, has a higher afﬁnity for iron. Notably, only ecESCs, not
e-euESCs or n-euESCs, revealed a signiﬁcantly more intense afﬁ-
nity for iron over EpCs, and ecESCs could receive excess iron from
EpCs via TfR1 (Fig. 4). Thus far, we are not able to conclude whe-
ther direct cell contact is necessary or not. Mesenchymal cells,
such as muscle and blood cells, originally derived from mesoderm,
have a high afﬁnity for iron. ESCs are derived from mesenchymal
cells. We therefore speculate that ecESCs regained this original
characteristic of mesodermal cells by genetic/epigenetic processes.
It is generally accepted that ecESCs play a role in the progression of
endometriosis via cytokine production [42]. However, the present
study demonstrates that ecESCs play a role, at least in part, in
preventing endometrial epithelial cells from excess iron-mediated
oxidative DNA damage leading to carcinogenesis.
There are two limitations in the present study. Catalytic Fe(II) is
completely dependent on HMRhoNox-M probe, which is accu-
mulated mainly in lysosomes. Thus, we cannot rule out the pos-
sibility that distribution and amounts of catalytic Fe(II) may be
different in other organelles including nucleus. We used Ishikawa
endometrioid carcinoma cells as a model of endometrial epithelial
cells.
There are two clinical indications, as well. An abundance of
stromal cells with a deﬁciency in epithelial cells in ovarian en-
dometriosis reveals a theoretical low risk for carcinogenesis, and
vice versa. If we can generate ecESCs from other somatic cells,
presumably via iPS cell technique, transplantation of those cells
may work to collect excess iron from epithelial/mesothelial cells to
prevent carcinogenesis [43].5. Conclusion
We showed, for the ﬁrst time, that catalytic ferrous iron is
abundant in endometriotic lesions, which is, at least in part, de-
pendent on alterations in the expression of TfR1 and ferroportin.
Furthermore, we demonstrated that ectopic stromal cells revealed
distinct iron metabolism for storage of excess iron and could re-
ceive excess iron from epithelial cells.Competing interests
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